Increased neutralization capacity of TNF-α in sera of relapsing remitting multiple sclerosis patients is not related to soluble TNF-α receptors or anti-TNF-α autoantibody levels-Reference-Cited by-同舟云学术

Increased neutralization capacity of TNF-α in sera of relapsing remitting multiple sclerosis patients is not related to soluble TNF-α receptors or anti-TNF-α autoantibody levels

Published:2015-09 Issue: Volume:286 Page:83-85
ISSN:0165-5728
Container-title:Journal of Neuroimmunology
language:en
Short-container-title:Journal of Neuroimmunology

Author:

Mausner-Fainberg Karin,Regev Keren,Kolb Hadar,Vaknin-Dembinsky Adi,Karni Arnon^ORCID

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,Immunology,Immunology and Allergy

Reference10 articles.

1. Oligodendrocyte/myelin injury and repair as a function of the central nervous system environment;Antel;Clin. Neurol. Neurosurg.,2006

2. Inflammatory demyelinating events following treatment with anti-tumor necrosis factor;Fromont;Cytokine,2009

3. TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis;Gregory;Nature,2012

4. TNF neutralization in MS: results of a randomized, placebo-controlled Multicenter study. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group;Group;Neurology,1999

5. Cytokine accumulations in CSF of multiple sclerosis patients: frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6;Hauser;Neurology,1990

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic Immunomodulatory Effects of Codonopsis pilosula Glucofructan on S180 Solid-Tumor-Bearing Mice;International Journal of Molecular Sciences;2023-10-26

2. The adaptation model of immunity: A new insight into aetiology and treatment of multiple sclerosis;Scandinavian Journal of Immunology;2023-01-31

3. Therapeutic consequences in patients with both inflammatory rheumatic diseases and multiple sclerosis;Rheumatology;2022-11-28

4. Targeting Inflammatory Mediators in Epilepsy: A Systematic Review of Its Molecular Basis and Clinical Applications;Frontiers in Neurology;2022-03-11

5. CNS Demyelination with TNF-α Blockers;Current Neurology and Neuroscience Reports;2017-03-21